MONTREAL--(BUSINESS WIRE)-- At the 2011 Annual Meeting of the Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), the companies i2A Canada and Bruker Ltd. announced ...
The new MALDI Tissuetyper based on the rapifleX instrument re-defines the key performance measures for MALDI imaging and allows for completely new projects and measurement strategies. The rapifleX ...
Bruker Corporation BRKR recently announced a collaboration and quality agreement with the medical device company, Accelerate Diagnostics Inc. AXDX. The agreement enables the validation of Bruker’s ...
Watch this live demo from Bruker's lab to see the MALDI MS polymer analysis workflows from beginning to end. We will showcase several different Bruker MALDI instruments featuring advanced new ...
The firm bought selected assets in Glasgow, UK for the development, validation and commercialization of molecular assays for applications in microbiology. It includes lab infrastructure and IP in the ...
GENEVA--(BUSINESS WIRE)--At the 4 th Congress of European Microbiologists (Federation of European Microbiological Societies, or FEMS) meeting in Geneva, Bruker announces a collaboration with the ...
Bruker said today that it launched the second phase of an ongoing collaboration with SISCAPA Assays Technologies (SAT), intended to exploit the high throughput, robustness, and ease of use of ...
neofleX is a versatile, high-performance, and easy-to-use multiomics MSI system for biopharma, translational and clinical researchers neofleX Imaging Profiler MALDI-TOF/TOF with proprietary smartbeam ...
At the ASM Microbe 2025 conference, Bruker announced that its MALDI Biotyper ® sirius and sirius one systems have been awarded the ACT Label, a mark of excellence in environmental accountability, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results